Effective Sample Size for Computing Prior Hyperparameters in Bayesian Phase I–II Dose-Finding

Clinical Trials - United Kingdom
doi 10.1177/1740774514547397
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

A Dose-Schedule Finding Design for Phase I-Ii Clinical Trials

Journal of the Royal Statistical Society. Series C: Applied Statistics
UncertaintyStatisticsProbability
2015English

Operating Characteristics of Restrictions on Skipping Dose Level for Adaptive Dose-Finding Method in Two-Agent Phase I Trials

Japanese Journal of Biometrics
2015English

Innovative Considerations on a Phase 2a Dose-Finding Strategy Using Bayesian Methods and McP-Mod

Trials
MedicinePharmacology
2015English

A Double-Blinded Randomised Placebo-Controlled Phase II Trial to Evaluate High Dose Rifampicin for Tuberculous Meningitis: A Dose Finding Study

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

A Bayesian Dose Finding Design for Oncology Clinical Trials of Combinational Biological Agents

Journal of the Royal Statistical Society. Series C: Applied Statistics
UncertaintyStatisticsProbability
2013English

Phase I Dose-Finding Study of Eribulin and Capecitabine for Metastatic Breast Cancer: JBCRG-18 Cape Study

Breast Cancer
Nuclear MedicineRadiologyPharmacologyOncologyImagingMedicine
2017English

Efficiency of Bayesian Approaches in Quantile Regression With Small Sample Size

Asian Journal of Probability and Statistics
2018English

A Bayesian Dose-Finding Design Incorporating Toxicity Data From Multiple Treatment Cycles

Statistics in Medicine
EpidemiologyStatisticsProbability
2016English

A Bayesian Dose-Finding Design for Drug Combination Clinical Trials Based on the Logistic Model

Pharmaceutical Statistics
StatisticsProbabilityPharmacology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy